Navigation Links

Biology Technology

U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis

3/22/2017
TARRYTOWN, N.Y. , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research initiative among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate genetic sequence data from the 500,000 volunteer participants in the U.K. Biobank resource. The initiative will enable researchers to gain valuable insights to support advances i... [Comments]

Worcester Polytechnic Institute Team Grows Heart Tissue on Spinach Leaves

3/22/2017
Worcester, Mass. (PRWEB) March 22, 2017 Researchers face a fundamental challenge as they seek to scale up human tissue regeneration from small lab samples to full-size tissues, bones, even whole organs to implant in people to treat disease or traumatic injuries: how to establish a vascular sy... [Comments]

Ascendis Pharma A/S Reports Full Year 2016 Financial Results

3/22/2017
COPENHAGEN, Denmark , March 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced financial results for the full year ended December 31, 2016. "2016 was a significant year for our company as we broadened our pipeline and pursu... [Comments]

UBM and Massachusetts Medical Device Industry Council (MassMEDIC) Partner for Third Annual Massachusetts Medtech Week

3/22/2017
SANTA MONICA, Calif. , March 22, 2017  UBM and the Massachusetts Medical Device Industry Council (MassMEDIC) are proud to announce their extended partnership and the third annual Massachusetts Medtech Week. Massachusetts Medtech Week will be headlined by the 21 st Annual MassMEDIC Conference held in conjunction with UBM's BIOMEDevice Boston, taking place May 3-4... [Comments]

Leading Family Genomics Company Good Start Genetics Expands Payor Relationships to More than 130 Million Covered Lives

3/22/2017
CAMBRIDGE, Mass. , March 22, 2017 Good Start Genetics, a leading family genomics company, today announced that it has eclipsed the 130 million covered lives mark through its most recent payor addition, Blue Cross Blue Shield of Texas . With newly signed contracts nationally and others in advanced stages, the Company continues to enjoy strong payor acceptance based on the qu... [Comments]

Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017

3/22/2017
JERUSALEM , March 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Dr. Miriam Kidron , Oramed's Chief Scientific Officer, will deliver a presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," at the... [Comments]

Doctors Pathology Service (DPS) Joins Growing Biospecimens for Research Program Offered by iSpecimen and the Delaware Health Information Network (DHIN)

3/22/2017
LEXINGTON, Mass. , March 22, 2017   iSpecimen ®, the marketplace for human biospecimen collections, today announced that Doctors Pathology Service (DPS), a full-service anatomic pathology reference lab serving the mid-Atlantic region of the United States , has joined a program offered by iSpecimen and the Delaware Health Information Network (DHIN) to make human bi... [Comments]

Chronic Kidney Disease (CKD) Drugs Market to Reach US$15.8 Billion by 2024; Rise in Geriatric Population to Create Lucrative Opportunities for Players, Says TMR

3/22/2017
ALBANY, New York , March 22, 2017 The global chronic kidney disease drugs market is largely fragmented, states a research report by Transparency Market Research (TMR). The top four players, namely Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for a share of only 41.4% in this market in 2015. The prominent players in this market are focusing aggressively on... [Comments]

Biotechs Focus on Improving Cancer Pain Management for Enhanced Patient Care

3/22/2017
PALM BEACH, Florida , March 22, 2017 MarketNewsUpdates.com News Commentary  The traditional ways to treat pain management for various cancer conditions are being pressured as of late due to the rise of the opioid crisis. Non-narcotic pain therapy for cancer pain management has a dramatic impact on patient's quality of life as Biotech and Pharma compan... [Comments]

FACIT Announces Investment in Propellon Therapeutics

3/22/2017
TORONTO , March 22, 2017 /PRNewswire/ - FACIT announced a seed stage investment in Propellon Therapeutics (the "Company" or "Propellon"), a start-up created by FACIT focused on developing a portfolio of WDR5-targeted anti-cancer therapeutics. FACIT's investment, combined with non-dilutive capital, achieves a targeted $3.0M financing for the lead program. The seed funding enables Propellon to... [Comments]

Boston Biomedical Celebrates 10-Year Anniversary of its Founding and Announces Appointment of Patricia S. Andrews as Chief Executive Officer

3/22/2017
CAMBRIDGE, Mass. , March 22, 2017   Boston Biomedical , an industry leader in the development of next-generation cancer therapeutics designed to target cancer stemness pathways, today announced its Board of Directors has appointed Patricia S. Andrews as Chief Executive Officer, effective April 24, 2017. Ms. Andrews will succeed Chiang J. Li , M.D., FACP, who has led... [Comments]

Medicine Technology

Vagus Nerve Stimulation Market Growing at a CAGR of 9.63% During 2017 to 2021

3/22/2017
PUNE, India , March 23, 2017 ReportsnReports.com adds Global Vagus Nerve Stimulation Market 2017 - 2021, a latest research report. The global vagus nerve stimulation market analyst says one trend in market is shift of surgeons focus toward minimally invasive VNS procedures. Few years ago, VNS procedures were not popular or limited to few developed countries having high stand... [Comments]

VWR adquiere EPL Archives, Inc.

3/22/2017
RADNOR, Pennsylvania , 22 de marzo de 2017   VWR (NASDAQ: VWR), el proveedor independiente global líder de soluciones de productos y servicios para clientes de laboratorio y producción, ha anunciado hoy que ha adquirido EPL Archives, Inc., una organización de servicios biorrepositorios internacional que apoya a los clientes en todo el ciclo de vida de investigación de pro... [Comments]

Global Respiratory Care Devices Market to Reach $38.2 Billion by 2025 - Huge Growth Opportunity in Asia Pacific Region - Research and Markets

3/22/2017
DUBLIN , Mar. 22, 2017 Research and Markets has announced the addition of the "Global Respiratory Care Devices Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Respiratory care devices Market is poised to grow at a CAGR of around 10.9% over the next decade to reach approximately $38.27 billion by 2025. Th... [Comments]

DarioHealth Reports Fourth Quarter and Year End 2016 Results

3/22/2017
CAESAREA, Israel, March 22, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the three and twelve month period ended December 31, 2016. 2016 Highlights Record revenues of $2.8 million, increased 241% compared to the full year 2015  Sequen... [Comments]

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022

3/22/2017
LONDON , March 22, 2017  "Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022" report gives comprehensive insight on clinical and non-clinical issues involved with growth of global biosimilar insulin market. This report analyzes various aspects like rationale design of insulin molecule, mechanism of insulin in diabetes, engineering of synthetic... [Comments]

Update - Ampio Pharmaceuticals Provides Corporate Update

3/22/2017
ENGLEWOOD, Colo. , March 22, 2017 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), a leader in the development of Ampion™, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, today announced that it is re-issuing its previous release that was made on March 20, 2017 to incorporate certain disclosures that are required under the NYSE MKT C... [Comments]

China Pharmaceutical Packaging Industry Report, 2016-2021

3/22/2017
NEW YORK , March 22, 2017 Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, the market size will maintain the growth rate of about 10% and is expected to outnumber RMB140 billion in 2021, thanks to severe aging, the released two-... [Comments]

Serve You Acquires New England Mail Order Pharmacy

3/22/2017
MILWAUKEE , March 22, 2017 Serve You Rx Vermont, LLC, a wholly owned subsidiary of Serve You Custom Prescription Management, Inc. (Serve You), based in Milwaukee, Wisconsin , has acquired the New England Mail Order Pharmacy (NEMOP) business, based in Middlebury, Vermont , from Pharmacy Health Services, Inc. "We're positioning ourselves for geographic expansion, so it w... [Comments]

ImaginAb Appoints Martyn Coombs as New Chief Executive Officer

3/22/2017
LOS ANGELES , March 22, 2017  ImaginAb Inc. today announced the appointment of Martyn Coombs as Chief Executive Officer. Joseph Limber , chairman of ImaginAb, said "At ImaginAb we have exciting science and technology. Martyn has a strong track record that is directly relevant to our business, particularly in commercializing and making step changes in the value of pro... [Comments]

Report: N.J. Hospitals Reduced Healthcare Costs by $641 Million Through Quality Improvement Initiative

3/22/2017
PRINCETON, N.J. , March 22, 2017 New Jersey's hospitals and health systems averted 77,342 cases of patient harm and saved $641 million in healthcare costs between 2012 and 2016, thanks to their participation in a national quality improvement program. The results reflect five years of progress under Partnership for Patients-New Jersey, part of a national initi... [Comments]

Cantel Medical to Present at the 16th Annual Needham & Company Healthcare Conference

3/22/2017
LITTLE FALLS, N.J. , March 22, 2017  CANTEL MEDICAL CORP. (NYSE: CMD ) announced today that Jorgen B. Hansen , President and CEO, will be presenting at the 16 th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York . The formal presentation is scheduled for Wednesday, April 5, 2017 at 3:00 p.m. ET. In addition, management... [Comments]

(Date:3/22/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... Lebovits , Chief Executive Officer, will provide an update ... Associates 2 nd Annual Neuroscience Biopartnering and Investment ... the New York Academy of Sciences. ...
(Date:3/22/2017)... , March 22, 2017   Invitae ... growing genetic information companies, today announced the availability ... of Spinal Muscular Atrophy (SMA) , a ... lethal genetic disorders among infants as well as ... childhood. The new test, announced during the American ...
(Date:3/20/2017)... (PRWEB) , ... March 20, 2017 , ... ... for pharmaceutical and biotech companies, recently announced it will debut a brand new ... York City. The intelliVessel is controlled by a touch screen panel and features ...
(Date:3/20/2017)... (PRWEB) , ... March 20, 2017 , ... ... Colony Counter, a customizable plug & play system that counts Peel Plate microbial ... tests. , This secure, stand-alone unit has an internal computer, and is ...
Breaking Biology Technology:
(Date:3/22/2017)... , March 22, 2017  Ablation is the ... a wide range of purposes, from cancerous or ... conducting cardiac tissue in atrial fibrillation and others. ... pushing the researchers to innovate and improvise existing ... The ablation device global market is expected to ...
(Date:3/22/2017)... 2017  Applied BioMath ( www.appliedbiomath.com ), the ... and development, today announced the latest line-up of ... is a day full of presentations, posters, and ... community. The focus is to learn about how ... drug research and development. The event ...
(Date:3/22/2017)... A new independent study demonstrates that ... ultraviolet-C (UV-C) disinfection solution of choice for combating ... Published in the March issue of the ... peer-reviewed study of UV-C disinfection systems detailed the ... and Rochester General Hospital. According to the study, ...
Breaking Medicine Technology: